Literature DB >> 30235119

Scan-Time Corrections for 80-100-min Standardizetd Uptake Volume Ratios to Measure the 18F-AV-1451 Tracer for Tau Imaging.

Mark He, Suzanne L Baker, Vyoma D Shah, Samuel N Lockhart, William J Jagust.   

Abstract

The 18F-AV-1451 PET tracer binds to tau, an Alzheimer's disease biomarker. The standardized uptake value ratio (SUVR) 80-100 min window is widely used to quantify tau binding, although 18F-AV-1451 continues increasing relative to a reference region in regions with tau deposition. Left uncorrected, acquisition time inaccuracies can lead to errors from -4% to 6% in 20-min SUVR measurements in subjects with Alzheimer's disease. In 40 subjects with scans from 75-115 min following 18F-AV-1451 injection, we created 20-min reconstructions (4×5 min) of start-times ranging from 75-85 min, as proxies of offset scans and calculated the mean in regions of interest (ROIs). We developed a segmented least squares (SLS) method to obtain error-minimizing weighting coefficients for 18F-AV-1451 ROIs that best predict SUVR 80-100 from weighted means of SUVRs from offset start-times. We compared residual errors of our SLS method to those in: 1) uncorrected offset 20-min-SUVRs; 2) the mean of five-min frames within the 80-100 window; and 3) a least-squares interpolation method. We evaluated errors induced by start-time offset on SUVRs for each method. TheSLS, which corrected using least-squares coefficients of 5-min components, consistently reduced errors across all offset starttimes. Effect size analysis for simulated clinical longitudinal 18F-AV-1451 drug trials showed that uncorrected 20-min offset SUVRs would require up to 20% more participants to detect treatment effects compared with using SLS. Correction of SUVR scan-time errors by SLS minimizes errors compared with other correction methods and may be extended to other scanners and tracers.

Entities:  

Year:  2018        PMID: 30235119      PMCID: PMC6475617          DOI: 10.1109/TMI.2018.2870441

Source DB:  PubMed          Journal:  IEEE Trans Med Imaging        ISSN: 0278-0062            Impact factor:   10.048


  19 in total

1.  Understanding the standardized uptake value, its methods, and implications for usage.

Authors:  Joseph A Thie
Journal:  J Nucl Med       Date:  2004-09       Impact factor: 10.057

2.  Accelerated image reconstruction using ordered subsets of projection data.

Authors:  H M Hudson; R S Larkin
Journal:  IEEE Trans Med Imaging       Date:  1994       Impact factor: 10.048

3.  Key cost drivers of pharmaceutical clinical trials in the United States.

Authors:  Aylin Sertkaya; Hui-Hsing Wong; Amber Jessup; Trinidad Beleche
Journal:  Clin Trials       Date:  2016-02-08       Impact factor: 2.486

4.  Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.

Authors:  Adam J Schwarz; Peng Yu; Bradley B Miller; Sergey Shcherbinin; James Dickson; Michael Navitsky; Abhinay D Joshi; Michael D Devous; Mark S Mintun
Journal:  Brain       Date:  2016-03-02       Impact factor: 13.501

5.  Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging.

Authors:  Suzanne L Baker; Samuel N Lockhart; Julie C Price; Mark He; Ronald H Huesman; Daniel Schonhaut; Jamie Faria; Gil Rabinovici; William J Jagust
Journal:  J Nucl Med       Date:  2016-09-01       Impact factor: 10.057

6.  Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurements.

Authors:  Rebecca L McNamee; Seong-Hwan Yee; Julie C Price; William E Klunk; Bedda Rosario; Lisa Weissfeld; Scott Ziolko; Michael Berginc; Brian Lopresti; Steven Dekosky; Chester A Mathis
Journal:  J Nucl Med       Date:  2009-02-17       Impact factor: 10.057

7.  PET Imaging of Tau Deposition in the Aging Human Brain.

Authors:  Michael Schöll; Samuel N Lockhart; Daniel R Schonhaut; James P O'Neil; Mustafa Janabi; Rik Ossenkoppele; Suzanne L Baker; Jacob W Vogel; Jamie Faria; Henry D Schwimmer; Gil D Rabinovici; William J Jagust
Journal:  Neuron       Date:  2016-03-02       Impact factor: 17.173

8.  Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.

Authors:  Sylvia Villeneuve; Gil D Rabinovici; Brendan I Cohn-Sheehy; Cindee Madison; Nagehan Ayakta; Pia M Ghosh; Renaud La Joie; Samia Kate Arthur-Bentil; Jacob W Vogel; Shawn M Marks; Manja Lehmann; Howard J Rosen; Bruce Reed; John Olichney; Adam L Boxer; Bruce L Miller; Ewa Borys; Lee-Way Jin; Eric J Huang; Lea T Grinberg; Charles DeCarli; William W Seeley; William Jagust
Journal:  Brain       Date:  2015-05-06       Impact factor: 13.501

9.  Longitudinal tau PET in ageing and Alzheimer's disease.

Authors:  Clifford R Jack; Heather J Wiste; Christopher G Schwarz; Val J Lowe; Matthew L Senjem; Prashanthi Vemuri; Stephen D Weigand; Terry M Therneau; Dave S Knopman; Jeffrey L Gunter; David T Jones; Jonathan Graff-Radford; Kejal Kantarci; Rosebud O Roberts; Michelle M Mielke; Mary M Machulda; Ronald C Petersen
Journal:  Brain       Date:  2018-05-01       Impact factor: 13.501

10.  Correction of scan time dependence of standard uptake values in oncological PET.

Authors:  Jörg van den Hoff; Alexandr Lougovski; Georg Schramm; Jens Maus; Liane Oehme; Jan Petr; Bettina Beuthien-Baumann; Jörg Kotzerke; Frank Hofheinz
Journal:  EJNMMI Res       Date:  2014-04-03       Impact factor: 3.138

View more
  1 in total

1.  Evaluation of [18F]-JNJ-64326067-AAA tau PET tracer in humans.

Authors:  Suzanne L Baker; Karine Provost; Wesley Thomas; A J Whitman; Mustafa Janabi; Mark E Schmidt; Maarten Timmers; Hartmuth C Kolb; Gil D Rabinovici; William J Jagust
Journal:  J Cereb Blood Flow Metab       Date:  2021-07-14       Impact factor: 6.960

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.